April 24, 2019 / 6:24 AM / 3 months ago

BRIEF-Shield Therapeutics Announces Major Extension To Approval In Switzerland

April 24 (Reuters) - Shield Therapeutics PLC:

* MAJOR EXTENSION TO APPROVAL IN SWITZERLAND

* SWISSMEDIC APPROVES FERACCRU TO TREAT IRON DEFICIENCY WITH OR WITHOUT ANAEMIA IN ADULTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below